These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7661091)

  • 1. Desired mechanisms of drugs for ventricular arrhythmia: class III antiarrhythmic agents.
    Lipka LJ; Dizon JM; Reiffel JA
    Am Heart J; 1995 Sep; 130(3 Pt 1):632-40. PubMed ID: 7661091
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electropharmacological basis of antiarrhythmic drugs and treatment of ventricular arrhythmias].
    Nakaya H
    Nihon Yakurigaku Zasshi; 2008 Jun; 131(6):446-51. PubMed ID: 18552447
    [No Abstract]   [Full Text] [Related]  

  • 3. Ventricular arrhythmias, Part III: Benefits and risks of antiarrhythmic therapy.
    Grauer K; Gums J
    J Am Board Fam Pract; 1988; 1(4):255-66. PubMed ID: 3066124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of antiarrhythmic drugs on canine ventricular arrhythmia models].
    Hashimoto K
    Nihon Yakurigaku Zasshi; 1989 Feb; 93(2):29-39. PubMed ID: 2656435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic drugs--class IV.
    Rowland E
    Eur Heart J; 1987 Mar; 8 Suppl A():61-3. PubMed ID: 3556178
    [No Abstract]   [Full Text] [Related]  

  • 6. Classification of antiarrhythmic drugs.
    Kutalek SP; McCormick DJ
    Am Fam Physician; 1988 Oct; 38(4):261-6. PubMed ID: 2902778
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness?
    Hashimoto K; Haruno A; Matsuzaki T; Sugiyama A; Akiyama K
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():805-17. PubMed ID: 1657110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic management of ventricular arrhythmias.
    Benz MR
    Crit Care Nurs Q; 1991 Nov; 14(3):8-15. PubMed ID: 1933547
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of ventricular arrhythmias.
    Fogoros RN
    Am Fam Physician; 1986 Mar; 33(3):236-46. PubMed ID: 3953344
    [No Abstract]   [Full Text] [Related]  

  • 10. [Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents].
    Fujiki A
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):253-60. PubMed ID: 16536075
    [No Abstract]   [Full Text] [Related]  

  • 11. Measuring antiarrhythmic drug efficacy by suppression of asymptomatic ventricular arrhythmias.
    Winkle RA
    Ann Intern Med; 1979 Sep; 91(3):480-2. PubMed ID: 475177
    [No Abstract]   [Full Text] [Related]  

  • 12. [Selection of antiarrhythmic drugs].
    Hayakawa H; Atarashi H
    Kokyu To Junkan; 1992 Dec; 40(12):1157-63. PubMed ID: 1480827
    [No Abstract]   [Full Text] [Related]  

  • 13. [Class-I antiarrhythmic drugs].
    Kuga K; Sugishita Y
    Nihon Rinsho; 1996 Aug; 54(8):2110-6. PubMed ID: 8810785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of antiarrhythmic drugs.
    Frumin H; Behrens S; Martyn R; Goldberg MJ; Rubenfire M; Kerin N
    J Clin Pharmacol; 1991 Nov; 31(11):1070-80. PubMed ID: 1753011
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of use of antiarrhythmic drugs.
    Mehta D; Saxena A
    Indian Heart J; 1990; 42(6):445-50. PubMed ID: 2098318
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiarrhythmic therapy for ventricular arrhythmias.
    Zimmermann M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S59-64. PubMed ID: 1723121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-arrhythmia agents in ventricular arrhythmias].
    Wever EF; Robles de Medina EO; Hauer RN
    Ned Tijdschr Geneeskd; 1989 Apr; 133(16):803-8. PubMed ID: 2725733
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on new antiarrhythmic drugs.
    Morton PG
    Crit Care Nurs Clin North Am; 1994 Mar; 6(1):69-83. PubMed ID: 8192885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular arrhythmias, conclusion: new agents, additional treatment modalities, and overall approach to the problem.
    Grauer K; Gums J
    J Am Board Fam Pract; 1988; 1(4):267-73. PubMed ID: 3066125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.